2022 Senate Bill 994 / Public Act 84

Create another government opioid commission

Introduced in the Senate

March 24, 2022

Introduced by Sen. Mark Huizenga (R-28)

To create a 24-member “opioid advisory commission” within the Legislative Council, a bipartisan entity that administers the legislative branch of state government. This would be comprised of specified political appointees and state officials, and would provide annual reviews of state government’s activities in this area. This would be in addition to a separate “Prescription Drug and Opioid Abuse Commission” in the Department of Licensing and Regulatory Affairs, which itself replaced an earlier Controlled Substances Advisory Commission, and an Advisory Committee on Pain and Symptom Management.

Referred to the Committee on Health Policy and Human Services

April 19, 2022

Reported without amendment

With the recommendation that the substitute (S-1) be adopted and that the bill then pass.

April 21, 2022

Passed in the Senate 33 to 0 (details)

Received in the House

April 26, 2022

Referred to the Committee on Judiciary

May 3, 2022

Reported without amendment

Without amendment and with the recommendation that the bill pass.

May 10, 2022

Passed in the House 91 to 13 (details)

To create a 24-member “opioid advisory commission” within the Legislative Council, a bipartisan entity that administers the legislative branch of state government. This would be comprised of specified political appointees and state officials, and would provide annual reviews of state government’s activities in this area. This would be in addition to a separate “Prescription Drug and Opioid Abuse Commission” in the Department of Licensing and Regulatory Affairs, which itself replaced an earlier Controlled Substances Advisory Commission, and an Advisory Committee on Pain and Symptom Management.

Signed by Gov. Gretchen Whitmer

May 19, 2022